Abstract：Objective To explore the clinical effect of Xuesaitong Injection combined with Atorvastatin Calcium in the treatment of diabetes with cerebral infarction.Methods A total of 120 patients with diabetes with cerebral infarction admitted to our hospital from January 2017 to January 2019 were selected as the research objects.They were divided into the control group (n=60) and the observation group (n=60) according to the random number table method.Patients in the control group were treated with Atorvastatin Calcium alone, and patients in the observation group were treated with Xuesaitong Injection combined with Atorvastatin Calcium.The National Institute of Health stroke scale (NIHSS)score, plasma viscosity, whole blood high shear viscosity, hematocrit before and after treatment, total effective rate of treatment and incidence of adverse reactions were compared between the two groups.Results There was no significant difference in NIHSS score between the two groups before treatment (P＞0.05).The NIHSS score of the observation group after treatment was lower than that of the control group, and the difference was statistically significant (P＜0.05).The total effective rate of treatment in the observation group was 93.33%, which was higher than 68.33% in the control group,with statistical significance (P＜0.05).There were no statistically significant differences in plasma viscosity, high blood viscosity and hematocrit before treatment between the two groups (P＞0.05).After treatment, the plasma viscosity, high blood viscosity and hematocrit in the observation group were lower than those in the control group, with statistical significances (P＜0.05).There was no significant difference in the total incidence rate of adverse reactions between the two groups (P＞0.05).Conclusion Combined treatment of Xuesaitong Injection and Atorvastatin Calcium in diabetic patients with cerebral infarction can effectively improve nerve function, enhance curative effect, improve blood viscosity, avoid adverse reactions, and increase safety.
Goto Y，Kumura E，Watabe T，et al.Prediction of Malignant Middle Cerebral Artery Infarction in Elderly Patients[J].J Stroke Cerebrovasc Dis，2016，25（6）：1389-1395.
[12]
Schaefer PW，Pulli B，Copen WA，et al.Combining MRI with NIHSS thresholds to predict outcome in acute ischemic stroke：value for patient selection[J].AJNR Am J Neuroradiol，2015，36（2）：259-264.
Li WT，Shafi N，Periakaruppan R，et al.Cerebral Aspergillosis in a Diabetic Patient Leading to Cerebral Artery Occlusion and Ischemic Stroke：A Case Report and Literature Review[J].J Stroke Cerebrovasc Dis，2015，24（1）：e39-e43.
[17]
Kazanci SY，Yesilbas O，Ersoy M，et al.Cerebral infarction and femoral venous thrombosis detected in a patient with diabetic ketoacidosis and heterozygous factor ⅤLeiden G1691A and PAI-1 4G/5G mutations[J].J Pediatr Endocrinol Metab，2015，28（9-10）：1183-1186.
京公网安备 11010502046607号